BioCentury | Aug 1, 2020
Tools & Techniques

Lurie winner and incoming Genentech R&D chief Aviv Regev looks to gene programs to untangle complex diseases

...and drug-resistant melanoma. In 2016, she and Sarah Teichmann, head of cellular genetics at the Wellcome Trust Sanger Institute...
BioCentury | May 30, 2020
Product Development

Sorting out COVID-19 consortia

...Four U.K. public health agencies, regional university hubs and large sequencing centers such as the Wellcome Sanger Institute...
...Trust Novartis AG AstraZeneca plc University of Oxford BARDA U.S. Biomedical Advanced Research and Development Authority CDC U.S. Food and Drug Administration (FDA) Wellcome Sanger Institute COVID-19 cov19pol cov19count cov19pol cov19count...
BioCentury | Mar 23, 2020
Tools & Techniques

U.K. consortium to map COVID-19 spread with genome sequencing

...group, with £20 million ($33 million) from the U.K. government and Wellcome Trust, comprises the Wellcome Sanger Institute...
...advances, and progress on countermeasures, is free to all who visit the site. Sandi Wong, Assistant Editor Wellcome Sanger Institute Covid-19 SARS-CoV-2 cov19count cov19count...
BioCentury | Sep 13, 2019
Company News

Sept. 12 Company Quick Takes: Atomwise in China deal; plus Ardelyx, GSK, Amarin, deCode

...in the UK Biobank. The Amgen Inc. (NASDAQ:AMGN) unit will conduct the work with the Wellcome Sanger Institute...
BioCentury | Aug 23, 2019
Preclinical News

Aug. 23 Preclinical Quick Takes: Mission Bio launches new feature in single-cell analysis platform; plus CRISPR-triggered hydrogel cargo release and more

...DNA, which induces single-stranded DNA cleavage and cargo release. Wellcome Sanger's transcriptional malaria map The Wellcome Sanger Institute...
...Hongjiang Li, Staff Writers Brigham Young University Brown University Massachusetts Institute of Technology Mission Bio Inc. University of California Santa Cruz Wellcome Sanger Institute Wyss...
BioCentury | Aug 9, 2019
Tools & Techniques

The next frontier for single-cell analysis

...Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland University of Texas MD Anderson Cancer Center, Houston, Texas Wellcome Sanger Institute...
BioCentury | Jun 21, 2019
Preclinical News

June 21 Preclinical Quick Takes: AnaptysBio targets PD-1 for immune disease; plus Forty Seven, Homology and moreBy BioCentury Staff

...knowledge of drug-target interactions and identified genomic rationales for synergy predictions. AstraZeneca and its partners Wellcome Sanger Institute...
...1 BC Staff Elzonris (tagraxofusp-erzs, SL-401) HMI-102 REGN4018 AnaptysBio Inc. AstraZeneca plc CD3 Forty Seven Inc. Homology Medicines Inc. Regeneron Pharmaceuticals Inc. Sage Bionetworks Stanford University Stemline Therapeutics Inc. Wellcome Sanger Institute Interleukin-3...
BioCentury | Jun 13, 2019
Tools & Techniques

GSK teams up with Doudna, Weissman labs to create CRISPR genomics center

...Targets partnership, GSK has participated in other CRISPR screens, including a large-scale study with The Wellcome Sanger Institute...
BioCentury | May 8, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: April 2019

...Broad Institute of Harvard and MIT ; Dana-Farber Cancer Institute ; Harvard Medical School ; Wellcome Sanger Institute...
BioCentury | Apr 16, 2019
Distillery Therapeutics

WRN inhibition for four cancer types with microsatellite instability

...Behan, F. et al. Nature ; published online Apr. 10, 2019 doi:10.1038/s41586-019-1103-9 CONTACT: Kosuke Yusa, Wellcome Sanger Institute...
...same affiliation as above email: simon.woehrle@boehringer-ingelheim.com Sandi Wong Boehringer Ingelheim GmbH Broad Institute of MIT and Harvard Dana-Farber Cancer Institute Wellcome Sanger Institute Werner...
Items per page:
1 - 10 of 112
BioCentury | Aug 1, 2020
Tools & Techniques

Lurie winner and incoming Genentech R&D chief Aviv Regev looks to gene programs to untangle complex diseases

...and drug-resistant melanoma. In 2016, she and Sarah Teichmann, head of cellular genetics at the Wellcome Trust Sanger Institute...
BioCentury | May 30, 2020
Product Development

Sorting out COVID-19 consortia

...Four U.K. public health agencies, regional university hubs and large sequencing centers such as the Wellcome Sanger Institute...
...Trust Novartis AG AstraZeneca plc University of Oxford BARDA U.S. Biomedical Advanced Research and Development Authority CDC U.S. Food and Drug Administration (FDA) Wellcome Sanger Institute COVID-19 cov19pol cov19count cov19pol cov19count...
BioCentury | Mar 23, 2020
Tools & Techniques

U.K. consortium to map COVID-19 spread with genome sequencing

...group, with £20 million ($33 million) from the U.K. government and Wellcome Trust, comprises the Wellcome Sanger Institute...
...advances, and progress on countermeasures, is free to all who visit the site. Sandi Wong, Assistant Editor Wellcome Sanger Institute Covid-19 SARS-CoV-2 cov19count cov19count...
BioCentury | Sep 13, 2019
Company News

Sept. 12 Company Quick Takes: Atomwise in China deal; plus Ardelyx, GSK, Amarin, deCode

...in the UK Biobank. The Amgen Inc. (NASDAQ:AMGN) unit will conduct the work with the Wellcome Sanger Institute...
BioCentury | Aug 23, 2019
Preclinical News

Aug. 23 Preclinical Quick Takes: Mission Bio launches new feature in single-cell analysis platform; plus CRISPR-triggered hydrogel cargo release and more

...DNA, which induces single-stranded DNA cleavage and cargo release. Wellcome Sanger's transcriptional malaria map The Wellcome Sanger Institute...
...Hongjiang Li, Staff Writers Brigham Young University Brown University Massachusetts Institute of Technology Mission Bio Inc. University of California Santa Cruz Wellcome Sanger Institute Wyss...
BioCentury | Aug 9, 2019
Tools & Techniques

The next frontier for single-cell analysis

...Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland University of Texas MD Anderson Cancer Center, Houston, Texas Wellcome Sanger Institute...
BioCentury | Jun 21, 2019
Preclinical News

June 21 Preclinical Quick Takes: AnaptysBio targets PD-1 for immune disease; plus Forty Seven, Homology and moreBy BioCentury Staff

...knowledge of drug-target interactions and identified genomic rationales for synergy predictions. AstraZeneca and its partners Wellcome Sanger Institute...
...1 BC Staff Elzonris (tagraxofusp-erzs, SL-401) HMI-102 REGN4018 AnaptysBio Inc. AstraZeneca plc CD3 Forty Seven Inc. Homology Medicines Inc. Regeneron Pharmaceuticals Inc. Sage Bionetworks Stanford University Stemline Therapeutics Inc. Wellcome Sanger Institute Interleukin-3...
BioCentury | Jun 13, 2019
Tools & Techniques

GSK teams up with Doudna, Weissman labs to create CRISPR genomics center

...Targets partnership, GSK has participated in other CRISPR screens, including a large-scale study with The Wellcome Sanger Institute...
BioCentury | May 8, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: April 2019

...Broad Institute of Harvard and MIT ; Dana-Farber Cancer Institute ; Harvard Medical School ; Wellcome Sanger Institute...
BioCentury | Apr 16, 2019
Distillery Therapeutics

WRN inhibition for four cancer types with microsatellite instability

...Behan, F. et al. Nature ; published online Apr. 10, 2019 doi:10.1038/s41586-019-1103-9 CONTACT: Kosuke Yusa, Wellcome Sanger Institute...
...same affiliation as above email: simon.woehrle@boehringer-ingelheim.com Sandi Wong Boehringer Ingelheim GmbH Broad Institute of MIT and Harvard Dana-Farber Cancer Institute Wellcome Sanger Institute Werner...
Items per page:
1 - 10 of 112